BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Ophthalmology 2005;89:960-963; doi:10.1136/bjo.2004.053397
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langman, M J S
Right arrow Articles by Stewart, P M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Langman, M J S
Right arrow Articles by Stewart, P M
Topic Collections
Right arrowRelevant Article

SCIENTIFIC REPORT

Systemic hypertension and glaucoma: mechanisms in common and co-occurrence

M J S Langman1, R J Lancashire2, K K Cheng2, P M Stewart1

1 Department of Medicine, University of Birmingham, Birmingham, UK
2 Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK

Correspondence to:
Correspondence to:
Professor M Langman
Department of Medicine, Queen Elizabeth Hospital, Birmingham B15 2TH, UK; m.j.s.langman{at}bham.ac.uk


ABSTRACT
Aims: To determine whether systemic hypertension and glaucoma might coexist more often than expected, with possible implications for treatment.

Methods: Case-control study using general practitioner database of patients with glaucoma matched with controls for age and sex.

Results: Hypertension was significantly more common in the 27 080 patients with glaucoma (odds ratio 1.29, 95% confidence intervals 1.23 to 1.36, p<0.001) than in controls. Treatment by oral ß blockade appeared to protect from risk (odds ratio 0.77, 95% CI 0.73 to 0.83, p<0.0001), but oral calcium channel antagonists or angiotensin converting enzyme (ACE) inhibitors did not (odds ratios 1.34, 1.24 to 1.44 and 1.16 1.09–1.24, respectively, p<0.0001 in each case). Oral corticosteroid treatment was associated with enhanced risk (odds ratio 1.78, 1.61 to 1.96).

Conclusion: Common pathogenetic mechanisms in ciliary and renal tubular epithelia may explain coincidence of glaucoma and systemic hypertension. The choice of cardiovascular treatment, could substantially influence glaucoma incidence, with ß blockade protecting and ACE inhibitors or calcium channel blockers not affecting underlying risk.


Abbreviations: ACE, angiotensin converting enzyme; GPRD, General Practitioner Research Database

Keywords: glaucoma; hypertension; ß blockade; sodium transport


Relevant Article

BJO at a glance
Creig Hoyt
Br. J. Ophthalmol. 2005 89: 931. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.